Academic Journal
Different antithrombotic strategies after coronary artery bypass grafting to prevent adverse events: a retrospective analysis
| Title: | Different antithrombotic strategies after coronary artery bypass grafting to prevent adverse events: a retrospective analysis |
|---|---|
| Authors: | Yi Shi, Shenglong Chen, Gang Liu, Bo Lian, Yu Chen, Lixue Zhang |
| Source: | Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-9 (2024) |
| Publisher Information: | BMC, 2024. |
| Publication Year: | 2024 |
| Collection: | LCC:Surgery LCC:Anesthesiology |
| Subject Terms: | Antithrombotic strategies, Coronary artery bypass grafting, Dual antiplatelet therapy, Surgery, RD1-811, Anesthesiology, RD78.3-87.3 |
| More Details: | Abstract Objective Coronary artery bypass grafting (CABG) is associated with antithrombotic therapy in terms of postoperative adverse events; however, it is still unknown whether the early use of such drugs after CABG is safe and effective. In this study, we aim to evaluate the relationship between different postoperative antithrombotic strategies and in-hospital adverse events in patients undergoing isolated coronary artery bypass grafting surgery. Methods This was a single-center, retrospective cohort analysis of patients undergoing isolated CABG due to coronary artery disease (CAD) between 2001 and 2012. Data were extracted from the Medical Information Mart for Intensive Care III database. The patients involved were divided into the ASA (aspirin 81 mg per day only) or DAPT (aspirin plus clopidogrel 75 mg per day) group according to the antiplatelet strategy. Patients were also stratified into subgroups based on the type of anticoagulation. The in-hospital risk of bleeding and adverse events was investigated and compared between groups. Propensity score matching (PSM) was performed to reduce the potential effects of a selection bias. Results A total of 3274 patients were included in this study, with 2358 in the ASA group and 889 in the DAPT group. Following the PSM, no significant difference was seen in the risk of major bleeding between the two groups according to the PLATO, TIMI or GUSTO criteria. There was no difference in the postoperative mortality. In subgroup analysis, patients given anticoagulant therapy had an increased incidence of bleeding-related events. Multivariable analysis revealed that postoperative anticoagulant therapy and the early use of heparin, but not DAPT, were independent predictors of bleeding-related events. Conclusions Postoperative DAPT was not associated with an increased occurrence of bleeding-related events in patients undergoing isolated CABG and appears to be a safe antiplatelet therapy. The addition of anticoagulants to antiplatelet therapy increased the risk of bleeding and should be considered cautiously in clinical practice. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 1749-8090 |
| Relation: | https://doaj.org/toc/1749-8090 |
| DOI: | 10.1186/s13019-024-02937-y |
| Access URL: | https://doaj.org/article/7a47d55fb5944ca7bf13e33bc8be48da |
| Accession Number: | edsdoj.7a47d55fb5944ca7bf13e33bc8be48da |
| Database: | Directory of Open Access Journals |
| Full text is not displayed to guests. | Login for full access. |
| ISSN: | 17498090 |
|---|---|
| DOI: | 10.1186/s13019-024-02937-y |
| Published in: | Journal of Cardiothoracic Surgery |
| Language: | English |